cGMP modulation therapeutics for sickle cell disease

cGMP modulation therapeutics for sickle cell disease

Nicola Conran, Lidiane Torres

ARTIGO

Inglês

Agradecimentos: The authors acknowledge grant support from FAPESP Brazil (Grant numbers 2018/08010-9, 2017/14594-0 and 2014/00984-3)

Abstract: Sickle cell disease (SCD) is an inherited disease caused by the production of abnormal hemoglobin (Hb) S, whose deoxygenation-induced polymerization results in red blood cell (RBC) sickling and numerous pathophysiological consequences. SCD affects approximately 300,000 newborns worldwide...

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

Fechado

cGMP modulation therapeutics for sickle cell disease

Nicola Conran, Lidiane Torres


										

cGMP modulation therapeutics for sickle cell disease

Nicola Conran, Lidiane Torres

    Fontes

    Experimental biology and medicine

    Vol. 244, no. 2 (Feb., 2019), p. 132-146